Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Dosing and Cardiac Injury in Fracture Surgery
NCT06808841Not yet recruiting
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of sufentanil in Myocardial injury (4 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoint: Serum Bone Morphogenetic Protein 6. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT06808841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06808841.